Check out the story by the UW Medicine Newsroom here.
Understanding mRNA and DNA vaccines in veterinary medicine
“It was my pleasure to lecture about mRNA and DNA vaccines at the ACVIM Forum 2023” -Dr. Fuller
Read more about Dr. Fuller’s lecture at ACVIM Forum 2023 here.
Catch Dr. Fuller April 27-28th at the Leveraging the mRNA Technology Workshop 2023
Do you want to explore how mRNA technology is revolutionizing modern medicine?
Join Dr. Deborah Fuller & a host of other key experts at this free workshop on 27 – 28 April in Washington, D.C.
Explore the bright future of #mRNA!
Sign-Up >> https://t.co/mRHIqxjyIn#mRNAWorkshop pic.twitter.com/uAAeTiRrDg
— Academic Medical Education (@Academic_MedEdu) March 30, 2023
Nucleic Acid Vaccines: The Beginning of a Medical Revolution
The COVID-19 pandemic brought mRNA vaccines to the forefront and realized, for the first time, their promise of providing a more rapid response to emerging infectious diseases than traditional vaccines. Ideally, vaccines of the future will not only be quick to develop but offer long-term stability at warm temperatures to overcome the barriers of the cold chain for worldwide distribution, achieve high-level efficacy in the immune-compromised and elderly, induce durable immunity in as few doses as possible and be capable of self-administration. Our lab is developing a second generation of nucleic acid (DNA and RNA) vaccines to address many of these gaps. Through novel immunogen design, innovative delivery, and formulations, the incorporation of genetic adjuvants, and combination approaches, we have developed new nucleic acid-based vaccine strategies that induce robust cellular and mucosal immune responses in addition to broad antibody responses that could further revolutionize vaccination by providing more effective and durable protection not only from coronaviruses but also influenza and other emerging infectious diseases.
Watch Dr. Fuller host the most attended Sino webinar to date, here.
Vaccine Makers Are Preparing for Bird Flu
Although most experts say bird flu is not an immediate threat to humans, efforts are underway to produce vaccines for H5N1 or another potential pandemic virus.
“RNA vaccines can be designed extremely quickly—you only need the genetic sequence of what the new variant is that’s emerging, and within weeks, [you] can have a vaccine already tested in animal models,” Fuller says.
Read more in the Scientific American
Making a Universal Flu Vaccine
How do you make a universal flu vaccine? A microbiologist explains the challenges, and how mRNA could offer a promising solution
Read Dr. Fuller’s piece in The Conversation.
Do new Covid ‘Scrabble’ variants make omicron boosters pointless? Here’s what experts say
Read what Dr. Fuller has to say on CNBC.
Researchers from NAU, Washington tackling an elusive Valley Fever vaccine
Dr. Fuller, along with NAU, have received a received a funding for a groundbreaking project that they hope will result in a safe and effective vaccine for Valley Fever.
Podcast Feature: KNX in Depth
FDA advisers approve a new COVID vaccine that uses old technology, listen to Dr. Fuller here.
An mRNA vaccine with a twist—it copies itself—protects against COVID-19
Fuller says a self-amplifying mRNA COVID-19 vaccine ideally would replace the two primary doses, giving it an even clearer benefit over its conventional relatives. A booster months later might still be warranted, as is encouraged now for the current mRNA vaccines. But self-amplifying mRNAs could also lead to more durable immune responses, Fuller suggests.
Read more in Science.